United Therapeutics Corporation
NASDAQ: UTHR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Martine A. Rothblatt
- Employees
- 1,305
- Headquarters
- Silver Spring, United States
- IPO year
- 1999
- Market cap
- $22.8B
- Website
- https://www.unither.com
Loading UTHR…
Loading profile data…Frequently asked questions about UTHR
What does United Therapeutics Corporation (UTHR) do?
United Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for individuals suffering from chronic and severe, often life-threatening, illnesses. Its operations span both the United States and international markets. The company's current commercial portfolio features se...
Where does UTHR trade?
United Therapeutics Corporation (UTHR) trades on the NASDAQ Global Select.
What sector is UTHR in?
United Therapeutics Corporation (UTHR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of United Therapeutics Corporation?
Martine A. Rothblatt is the chief executive officer of United Therapeutics Corporation (UTHR).
Where is United Therapeutics Corporation headquartered?
United Therapeutics Corporation is headquartered in United States.
Does UTHR pay a dividend?
United Therapeutics Corporation (UTHR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did UTHR go public?
United Therapeutics Corporation (UTHR) completed its initial public offering in 1999.